There are a group of people who smoke marijuana and it’s not because they are addicted to it, but by smoking marijuana, those people get pain reliefs from chronic pain. According to a new health study, it’s been found that the reason why so many people are showing up at state-approved marijuana program is that they want to get reliefs from chronic pain which might be hurting them more than anyone’s predictions. Some people will have to go through chemotherapy session which will give them an immense amount of anxiety also it makes a person’s body weak, and in that situation, those patients get prescribed marijuana as pain relief. Nowadays many organizations are protesting against the usability of marijuana because they think such type of things is destroying peoples health. However, now if we look into this health study published in journal health affairs, it shows another side of a story.
Researchers couldn’t find how much people are getting good benefits from smoking marijuana, but they think many patients with chronic pain have seen consuming it to feel better. Currently, more than 30 States in the united states if America allows marijuana for solving health-related problems and many doctors writes prescribed marijuana for those patients who really need it. However, some health expert criticizes government’s policy because they think the government has approved all those medicines which contain components of marijuana, but it has banned using marijuana by stating it is not good for health. Many states allowed using marijuana for curing post-traumatic experiences also some states believe it has no usability. Whether marijuana shall be considered as legal medicine or not is somehow getting a bigger issue in the USA.
Phone No: +1 716-359-0737
Lara is a perpetually traveling writer who focuses on trending tech, health and international e-commerce as seen from the ground. For the past three years, She has been traveling, doing research for a book which should be out in 2019. She has been featured in, interviewed by, or appeared on CNBC Squawk Box, Forbes.com, VICE, BBC World, and NPR Morning Edition.